Kristen Fortney - Sep 25, 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Executive Officer, Director
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Stock symbol
BIOA
Transactions as of
Sep 25, 2024
Transactions value $
$0
Form type
3
Date filed
9/25/2024, 04:44 PM
Previous filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIOA Common Stock 1.21M Sep 25, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 244K $10.27 Direct F1
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 116K $7.23 Direct F2
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 116K $10.85 Direct F3
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 708K $8.39 Direct F4
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 5.96K $3.08 By Spouse F5, F6
holding BIOA Stock Option (Right to Buy) Sep 25, 2024 Common Stock 49.8K $10.27 By Spouse F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on January 16, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date
F3 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F4 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F5 The option became fully vested on June 18, 2022.
F6 Represents an employee stock option directly held by the reporting person's spouse.
F7 The option vested or vests as to 1/120th of the total award monthly, with the first tranche vesting on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the option holder's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.